International Stem Cell CORP
ISCO· OTC
Released May 13, 2013, after the close
10-Q filed May 14, 2013, 44 days after period end · 0001193125-13-217562
| Metric | Q1 2013 | Q1 2012 | Q1 2011 |
|---|---|---|---|
| Revenue | $1.29M | $1.08M | $1.52M |
| Net Income | -$1.71M | -$2.68M | -$1.60M |
| EPS Diluted | -$0.02 | -$0.05 | -$0.02 |
International Stem Cell CORP · CIK 1355790 · Engraved from SEC EDGAR
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.